A new therapy was effective against ER-positive, HER2-negative breast cancers, the most common subtype. “These results will change how many breast cancers are treated,” says medical oncologist Dr.
Research at MSK Our research impact Research topics Core facilities & resources ...
We apply both precision gene editing and large-scale CRISPR screening in human pluripotent stem cells (hPSCs) to explore mechanisms underlying human development. Specifically, we are interrogating the ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Wednesday, March 19, 2025 - 1:00 p.m. to 2:00 p.m.